Cargando…
The Combination of Astragalus membranaceus and Angelica sinensis Inhibits Lung Cancer and Cachexia through Its Immunomodulatory Function
Lung cancer and its related cachexia are the leading cause of cancer death in the world. In this study, we report the inhibitory effect of the combined therapy of Astragalus membranaceus and Angelica sinensis, on tumor growth and cachexia in tumor-bearing mice. Lewis lung carcinoma cells were inocul...
Autores principales: | Wu, Tsung-Han, Yeh, Kun-Yun, Wang, Chen-Hsu, Wang, Hang, Li, Tsung-Lin, Chan, Yi-Lin, Wu, Chang-Jer |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6875282/ https://www.ncbi.nlm.nih.gov/pubmed/31781219 http://dx.doi.org/10.1155/2019/9206951 |
Ejemplares similares
-
Effect of Dangguibohyul-Tang, a Mixed Extract of Astragalus membranaceus and Angelica sinensis, on Allergic and Inflammatory Skin Reaction Compared with Single Extracts of Astragalus membranaceus or Angelica sinensis
por: Choi, You Yeon, et al.
Publicado: (2016) -
Insights
into the
Mechanism of Supramolecular Self-Assembly
in the Astragalus membranaceus–Angelica sinensis Codecoction
por: Liang, Pan, et al.
Publicado: (2023) -
Prediction and validation of potential molecular targets for the combination of Astragalus membranaceus and Angelica sinensis in the treatment of atherosclerosis based on network pharmacology
por: Wang, Tianyue, et al.
Publicado: (2022) -
Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
por: Cao, Shengnan, et al.
Publicado: (2022) -
Retracted: Network Pharmacology and Molecular Docking-Based Investigation of Potential Targets of Astragalus membranaceus and Angelica sinensis Compound Acting on Spinal Cord Injury
por: Markers, Disease
Publicado: (2023)